Statement of Presidential Spokesperson Harry Roque on Ivermectin

To ensure the safety and welfare of the public and at the same time avoid any unnecessary conflicts, the Food and Drug Administration (FDA) has been directed to take the lead in determining the course of action against the illegal trading/dispensing of Ivermectin. The Philippine National Police (PNP) cannot arbitrarily determine on their own which drug/s should not be on the market. All operations to apprehend or seize goods must be done in coordination with the FDA.

The Palace further underscores what is being ordered to stop is the sale/trade of Ivermectin for veterinary use that has been repackaged as human grade, including those that have not been determined by competent authorities as safe to be used in humans.

Having said this, we advise the public to seek the advice of medical practitioners before taking medicines and/or supplements.

The President is closely monitoring the developments concerning Ivermectin here and abroad. He has even directed the Presidential Management Staff (PMS) to give him weekly updates on Ivermectin studies and FDA-related clearance.

Popular

Malacañang urges caution on calls to expel Chinese envoy

By Ruth Abbey Gita-Carlos | Philippine News Agency Malacañang on Wednesday acknowledged calls for action against Chinese Ambassador to the Philippines Jing Quan over his...

Malacañang: Armed group sheltering Sen. dela Rosa a threat to nat’l security

By Dean Aubrey Caratiquet After several months of manhunt operations, authorities said that they have already identified the whereabouts of Senator Ronald “Bato” dela Rosa,...

Malacañang presses probe into reported Atong Ang escape

By Darryl John Esguerra | Philippine News Agency Malacañang on Wednesday called for an investigation into possible lapses in law enforcement after Interior Secretary Jonvic...

PBBM, Japan reaffirm bilateral ties, regional cooperation

By Ruth Abbey Gita-Carlos | Philippine News Agency President Ferdinand R. Marcos Jr. and Japanese Prime Minister Sanae Takaichi on Tuesday reaffirmed their commitment to...